Craig Stuart Millian, Chief Commercial Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 2,000 shares at $4.25 ($9K) on 2020-03-17, disclosed to the SEC on 2020-03-18.
Open-market purchase of $8k CRBP by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CRBP | BUY | 2019-11-12 | $4K | — | Filing → |
| CRBP | BUY | 2019-08-16 | $8K | — | Filing → |
| CRBP | BUY | 2019-08-13 | $9K | — | Filing → |